Menu
  • Join
  • Login
  • Contact
 

Search abstracts


THE USE OF ANTINEOPLASTIC DRUGS AND RALATED REIMBURSEMENT POLICY IN CHINA

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: KUAI, Liping (Science and Technology Development Center of CPA, China)
  • Co-author(s): Yinyu zhou: administration office, Science&Technology development center of CPA, beijing, China
    Liping Kuai: policy research department, Science&technology development center of CPA, beijing, China
    Ran zhang: policy research department, Science@Technology Development Center of CPA, beijing, China
    Dongyan Xu: policy research department, Science & Technology Development Center of CPA, beijing, China
    Jingran liu: policy research department, Science and Technology Development Center of CPA, Beijing, China
  • Abstract:

    Background

     With the increase of cancer’s incidence, China's antineoplastic drugs’ market had developed rapidly.

    The Chinese government was highly concerned about antineoplastic drugs use and strive to increase the affordability of the antineoplastic drugs.

    Methods

    The use of antineoplastic drugs in the membership hospitals of CMEI were analyzed

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 21 September 2019

FIP Congresses